Effect on vein graft intimal hyperplasia of nuclear factor-κB decoy transfection using the second generation of HVJ vector

Journal of Cardiovascular Surgery

Volumn 48, Issue 4, 2007, Pages 463-470

  Shimizu, N ^a   Azuma, N ^a   Nishikawa, T ^b   Hirata, S ^a   Morishita, R ^b   Kaneda, Y ^b   Sasajima, T ^a,c  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NONE   (Japan)

Author keywords

Gene therapy; Hyperplasia; NF kappaB decoy; Tunica intima

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DOG; FEMORAL ARTERY; GENE EXPRESSION; GENETIC TRANSFECTION; MORPHOMETRICS; NONHUMAN; OLIGONUCLEOTIDE THERAPY; OUTCOME ASSESSMENT; PARAINFLUENZA VIRUS 1; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VEIN GRAFT; VEIN GRAFT DISEASE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DOGS; FEMORAL ARTERY; GENETIC VECTORS; HYPERPLASIA; NF-KAPPA B; OLIGONUCLEOTIDES; RNA, MESSENGER; SAPHENOUS VEIN; SENDAI VIRUS; TRANSFECTION; TUNICA INTIMA;

EID: 35848967593     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Budd JS, Brennan J, Beard JD, Warren H, Burton PR, Bell PR. Infrainguinal bypass surgery: factors determining late graft patency. Br J Surg 1990;77:1382-7.
2. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson R, Scher LA et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
3. Taylor LM Jr, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-206.
4. Sasajima T, Kubo Y, Kokubo M, Izumi Y, Inaba M. Comparison of reversed and in situ saphenous vein grafts for infragenicular bypass: experience of two surgeons. Cardiovasc Surg 1993;1:38-43.
5. Darling RC, Roddy SP, Chang BB, Paty PS, Kreienberg PB, Maharaj D et al. Long-term results of revised infrainguinal arterial reconstructions. J Vasc Surg 2002;35:773-8.
6. Becquemin J-P. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. N Engl J Med 1997;337:1726-31.
7. Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 2004;38:1178-85.
8. Ehsan A, Mann MJ, Dell'Acqua G, Dzau VJ. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg 2001;121:714-22.
9. Mann MJ, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polak JF et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 1999;354:1493-8.
10. Kent KC. Intimal hyperplasia/restenosis of peripheral vessels-is the problem solved? J Jpn Col Angiol 2005;45:702.
11. Barnes PJ, Karin M. Nuclear factor-kB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
12. Monaco C, Paleolog E. Nuclear factor kB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 2004;61:671-82.
13. Davies MG, Hagen PO. Pathophysiology of vein graft failure: A review. Eur J Vasc Endovasc Surg 1995;9:7-18.
14. Motwani JG, Topoi EJ. Aortocoronary saphenous vein graft disease pathogenesis, predisposition, and prevention. Circulation 1998;97: 916-31.
15. Itoh H, Komori K, Funahashi S, Okadome K, Sugimachi K. Intimal hyperplasia of experimental autogenous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis 1994;110:259-70.
16. Ishida M, Komori K, Yonemitsu Y, Taguchi K, Onohara T, Sugimachi K. Immunohistochemical phenotypic alteration of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling. Atherosclerosis 2001;154:345-54.
17. Kohler TR, Kirkman RT, Clowes AW. The effect of rigid external support in vein graft adaptation to the arterial circulation. J Vasc Surg 1989;9:277-85.
18. Hoch JR, Stark VK, van Rooijen N, Kim JL, Nutt MP, Warner TF. Macrophage depletion alters vein graft intimal hyperplasia. Surgery 199;126:428-37.
19. Adcock GD, Adcock OT, Wheeler JR, Gregory RT, Snyder SO, Gayle RG et al. Arterialization of reversed autogenous vein grafts: quantitative light and electron microscopy of canine jugular vein grafts harvested and implanted by standard or improved techniques. J Vasc Surg 1987;6:283-95.
20. Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S et al. Nuclear factor-kB activity and arterial response to balloon injury. Atherosclerosis 1997;131:59-66.
21. Morishita R, Higaki J, Tomita N, Ogihara T. Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 1998;82:1023-8.
22. Yoshimura S, Morishita R, Hayashi K, Yamamoto K, Nakagami H, Kaneda Y et al. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kB binding site as a novel molecular strategy. Gene Ther 2001;8:1635-42.
23. National Institute of Mental Health [homepage on the Internet]. Bethesda: NIMH. Available from: zippy.nimh.nih.gov
24. Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzuki N et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 2002;6:219-26.
25. Shimamura M, Morishita R, Endoh M, Oshima K, Aoki M, Waguri S et al. HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun 2003;300:464-71.
26. Bush HL, Jakubowski JA, Curl GR, Deykin D, Nabseth DC. The natural history of endothelial structure and function in arterialized vein grafts. J Vasc Surg 1986;3:204-15.
27. Huynh TT, Davies MG, Trovato MJ, Svendsen E, Hagen PO. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts. J Vasc Sur 1999;29:334-44.
28. Angelini GD, Passani SL, Brekenridge IM, Newby AC. Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts. Cardiovasc Res 1987;21:902-7.
29. Quist WC, LoGerfo FW. Prevention of smooth muscle cell phenotypic modulation in vein grafts: a histomorphometric study. J Vasc Surg 1992;16:225-31.
30. Sakaguchi T, Asai T, Belov D, Okada M, Pinsky DJ, Schmidt AM et al. Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation. J Thorac Cardiovasc Surg 2005;129:129-37.
31. Angelini GD, Bryan AJ, Williams HMJ, Morgan R, Newby AC. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 1990;99:433-9.
32. Zou Y, Hu Y, Mayr M, Dietrich H, Wick G, Xu Q. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res 2000;86:434-40.
33. Nakamura H, Kimura T, Ikegami H, Ogita K, Koyama S, Shimoya T et al. High efficient and minimally invasive in-vivo gene transfer to the mouse uterus using haemagglutinating virus of Japan (HVJ) envelope vector. Mol Hum Reprod 2003;9:603-9.
34. Schwartz LB, Moawad J, Svensson EC, Tufts RL, Meyerson SL, Baunoch D et al. Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts. J Vasc Surg 1999;29:874-83.
35. Eton D, Terramani TT, Wang Y, Takahashi AM, Nigro JJ, Tang L et al. Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector. J Vasc Surg 1999;29:863-73.
36. Eton D, Yu H, Wang Y, Raines J, Striker G, Livingstone A. Endograft technology: a delivery vehicle for intravascular gene therapy. J Yasc Surg 2004;39:1066-73.
37. Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K et al. Development of safe and efficient novel gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9:372-80.
38. DeGregoti J, Koealik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S- regulatory genes. Mol Cell Biol 1995;15:4215-24.
39. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.